2型糖尿病患者胰岛素注射器规范使用研究进展  

Research Progress on the Standard use of Insulin Syringes in Type 2 Diabetes

作　　者：王莲 WANG Lian(First Department of Tianjin Anning Hospital,Tianjin 300000)

机构地区：[1]天津市安宁医院一科,天津300000

出　　处：《中国医疗器械信息》2021年第8期35-36,共2页China Medical Device Information

摘　　要：胰岛素是糖尿病患者治疗应用最为有效和最为广泛的药物,我国约有60%的糖尿病患者采用胰岛素进行治疗,但是这部分患者中血糖达标率不足40%,其很大原因在于胰岛素注射器使用不规范,进而降低了胰岛素治疗的效果。已有大量临床实践表明胰岛素注射器不规范使用会影响血糖控制效果,同时还会给患者自我管理带来风险。特别是对于那些合并精神疾病以及认知功能障碍患者来说,胰岛素注射器的规范使用显得更加重要。因此关于胰岛素注射器的规范使用近些年很多学者开展了一系列研究,本文对这些研究进展进行综述,以期为胰岛素注射器的规范使用提供借鉴。Insulin is the most effective and widely used drug in the treatment of diabetic patients.About 60%of diabetic patients in our country use insulin for treatment,but the rate of reaching the standard of blood glucose in these patients is less than 40%.The main reason is that the use of insulin syringes is not standardized,which reduces the effect of insulin treatment.A large number of clinical practices have shown that the irregular use of insulin syringes will affect the effect of blood glucose control,but also bring risks to patients’self-management.Especially for those patients with mental illness and cognitive dysfunction,the standard use of insulin syringes is more important.Therefore,in recent years,many scholars have carried out a series of research on the standard use of insulin syringes.This paper reviews these research progress in order to provide reference for the standard use of insulin syringes.

关 键 词：2型糖尿病 胰岛素注射器 规范使用 

分 类 号：R472[医药卫生—护理学]